Task: Answer the multiple-choice question.
Question: Which drug has a -60.518\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a Cc1ccc(NC(=O)C2CCN(c3cnccn3)CC2)cc1C
b CSc1nnc(SCC(=O)Nc2ccc3[nH]c(=O)[nH]c3c2)s1
c Cc1cc(NS(=O)(=O)c2ccc(NC(=O)C(C)Oc3ccc(Cl)cc3)cc2)no1
d CCCCN(C)CCN1C(=O)C2C(C(=O)Nc3ccc(Cl)cc3)C3C=CC2(O3)C1C(=O)NC1CCCCC1
Answer: d. CCCCN(C)CCN1C(=O)C2C(C(=O)Nc3ccc(Cl)cc3)C3C=CC2(O3)C1C(=O)NC1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCN(C)CCN1C(=O)C2C(C(=O)Nc3ccc(Cl)cc3)C3C=CC2(O3)C1C(=O)NC1CCCCC1
CCCCN(C)CCN1C(=O)C2C(C(=O)Nc3ccc(Cl)cc3)C3C=CC2(O3)C1C(=O)NC1CCCCC1
3-[2-[butyl(methyl)amino]ethyl]-6-N-(4-chlorophenyl)-2-N-cyclohexyl-4-oxo-10-oxa-3-azatricyclo[5.2.1.01,5]dec-8-ene-2,6-dicarboxamide